IRIS
PATTI, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.833
EU - Europa 2.548
AS - Asia 2.227
SA - Sud America 317
AF - Africa 21
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.957
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.809
IE - Irlanda 1.141
CN - Cina 847
SG - Singapore 571
RU - Federazione Russa 420
UA - Ucraina 382
DE - Germania 373
HK - Hong Kong 371
TR - Turchia 330
BR - Brasile 290
IT - Italia 99
IN - India 66
FR - Francia 41
SE - Svezia 21
FI - Finlandia 18
BE - Belgio 16
GB - Regno Unito 15
CA - Canada 13
IQ - Iraq 11
AR - Argentina 10
BD - Bangladesh 8
ZA - Sudafrica 8
EC - Ecuador 7
MX - Messico 7
PK - Pakistan 7
EU - Europa 5
NL - Olanda 5
AU - Australia 4
ES - Italia 4
JO - Giordania 4
UZ - Uzbekistan 4
MA - Marocco 3
PL - Polonia 3
PY - Paraguay 3
TN - Tunisia 3
AT - Austria 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JP - Giappone 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CG - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 9.957
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.488
Dublin 1.139
Chandler 821
Santa Clara 386
Hong Kong 371
Izmir 317
Nanjing 312
Singapore 223
Boardman 193
Lawrence 189
Princeton 189
Wilmington 130
Moscow 126
Nanchang 104
Ashburn 93
New York 89
L'aquila 85
The Dalles 55
Pune 54
Shenyang 53
Hebei 42
Tianjin 40
Dallas 38
Jiaxing 31
Council Bluffs 30
San Mateo 30
Kunming 29
Norwalk 29
Beijing 27
Changsha 27
Los Angeles 26
Shanghai 21
Ann Arbor 20
Jinan 20
Lanzhou 17
São Paulo 17
Brussels 16
Mountain View 15
Zhengzhou 12
Helsinki 11
Changchun 10
Ningbo 10
Munich 9
Brooklyn 8
London 8
Des Moines 7
Belo Horizonte 6
Brasília 6
Montreal 6
Phoenix 6
Rio de Janeiro 6
Campinas 5
Curitiba 5
Fremont 5
Hangzhou 5
Istanbul 5
Porto Alegre 5
Redwood City 5
San Francisco 5
Ankara 4
Baghdad 4
Falkenstein 4
Guangzhou 4
Johannesburg 4
Lappeenranta 4
Seattle 4
Secaucus 4
Stockholm 4
Tashkent 4
Uberlândia 4
Amman 3
Atlanta 3
Boston 3
Chengdu 3
Chicago 3
Dearborn 3
Erbil 3
Frankfurt am Main 3
Fuzhou 3
Joinville 3
Juiz de Fora 3
New Delhi 3
Orange 3
Pelotas 3
Quito 3
Salvador 3
Tomsk 3
Turku 3
Altamira 2
Amsterdam 2
Arapiraca 2
Augusta 2
Barra Mansa 2
Bauru 2
Bremen 2
Brno 2
Cabo Frio 2
Capão da Canoa 2
Caraguatatuba 2
Cariacica 2
Totale 7.159
Salva come PNG Salva come JPEG
Nome #
Author`s Reply 86
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 84
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 82
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 81
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 73
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis 73
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 72
Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 72
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 71
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 69
Atorvastatin for reduction of myocardial damage during angioplasty trials 69
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. 69
Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question! 68
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 67
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study 67
Are we ready for a gender-specific approach in interventional cardiology? 67
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 66
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 66
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 66
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 66
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial 65
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: The prospective, multicentre observational PREvention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) 65
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 65
Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study 64
Apoptosis and post-infarction left ventricular remodeling 64
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly 64
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 64
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 64
Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents 64
Myocardial infarction during pregnancy and postpartum: A review 64
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention 63
Apoptosis in recent myocardial infarction 63
Early and long-term results of stenting of diffuse coronary artery disease 62
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 62
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 62
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 62
Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale 62
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations 61
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 61
Atorvastatin pretreatment in early percutaneous coronary intervention 61
Have statins beneficial anti-inflammatory as well as lipid-lowering effects 61
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 61
Untitled 60
Comparison of the Feasibility and Effectiveness of Transradial Coronary Angiography Via Right Versus Left Radial Artery Approaches (from the PREVAIL Study) 60
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 60
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 60
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study) 60
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 60
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 60
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 60
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 59
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 59
Editorial: Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction 59
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 59
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 59
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 59
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 59
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? 59
Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome 58
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 58
Combining Antiplatelet and Anticoagulant Therapies 58
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: An unusual case of myocardial rupture 58
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 57
Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study 57
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis 57
Improvement of myocardial ischemia by subclavian stent implantation in patients with internal mammary grafts: A case report and review of the literature 57
The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences 56
Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina 56
Key references: Basic fibrinolysis and thrombolysis selected references: 1987-1997 56
Platelets GP-IIB-IIA receptor inhibitors in ischemic patients 56
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy 56
Prasugrel versus clopidogrel 56
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 56
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 56
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 56
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 56
Association of virulent Helicobacter pylori strains with ischemic heart disease 55
Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis 55
Percutaneous coronary interventions and statin therapy 55
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients 55
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction 55
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy 54
Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report 54
Psychological stress as precipitating factor of the acute manifestations of ischemic cardiopathy 54
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis - A pilot study with ACTH-Depot plus tropisetron 54
Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery 54
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery - Results of the ARMYDA-3 (Atorvastatin for reduction of MYocardial dysrhythmia after cardiac surgery) study 54
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 54
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 54
Prevention of myocardial damage during coronary intervention 54
Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis 54
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial) 54
What is the role for Glycoprotein IIb/IIIa inhibitor use in the catheterisation laboratory in the current era? 54
The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation 54
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 54
Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation 54
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials 54
Statin loading for acute coronary syndromes 54
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention 54
Patients with atrial fibrillation and coronary events: Are we any closer to coming out from the labyrinth of the various antithrombotic strategies? 54
Totale 6.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020188 0 0 0 0 0 0 0 0 0 0 0 188
2020/20211.176 8 193 3 189 190 1 198 1 176 1 216 0
2021/2022509 1 0 5 5 15 3 9 61 68 5 84 253
2022/20232.682 218 87 46 211 196 239 0 159 1.387 11 78 50
2023/2024483 98 25 31 22 39 192 2 39 0 24 2 9
2024/20252.763 22 31 273 55 258 308 389 142 760 139 194 192
Totale 10.180